Oncoloxía Traslacional
![Foto de Oncoloxía Traslacional](/img/grupo.png)
![Foto de National University Cancer Institute](/img/noimage_org.png)
National University Cancer Institute
Singapur, SingapurPublicacións en colaboración con investigadores/as de National University Cancer Institute (1)
2020
-
Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial
The Lancet Respiratory Medicine, Vol. 8, Núm. 11, pp. 1132-1143